🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
A Phase I of Olaparib with Radiation Therapy in Patients With Inflammatory,...
Status
Completed
Location
Institut Curie
Start Date
2017-07-24
Trial ID
NCT03109080
Treatments Being Tested
This is an open-label, multicenter, phase Ib/II study of the combination of...
Status
Terminated
Location
Huntsman Cancer Institute at the University of Utah
Start Date
2022-09-23
Trial ID
NCT05405309
The purpose of this study is to test the safety of a new medication, Olapar...
Status
Completed
Location
Baptist Alliance Miami Cancer Institute
Start Date
2018-07-12
Trial ID
NCT03532880
This phase 1b trial is designed to evaluate the safety and tolerability of ...
Status
Not Yet Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2025-11-01
Trial ID
NCT07090369
Treatments Being Tested
The purpose of this research study is to evaluate the effectiveness of usin...
Status
Active Not Recruiting
Location
Indiana University Simon Comprehensive Cancer Center
Start Date
2022-09-02
Trial ID
NCT05366166
Treatments Being Tested
Accelerated, normofractionated radiotherapy is the treatment of choice in s...
Status
Unknown
Location
The Netherlands Cancer Institute
Start Date
2014-09-24
Trial ID
NCT02229656
Treatments Being Tested
Researchers are looking for new ways to treat types of breast cancer that a...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0066)
Start Date
2025-06-30
Trial ID
NCT06966700
This phase I trial studies the side effects and best dose of olaparib and o...
Status
Completed
Location
Mayo Clinic Hospital in Arizona
Start Date
2017-05-19
Trial ID
NCT02898207
Around 15-25% of ovarian cancer (OC) patients carry germ-line mutation in B...
Status
Unknown
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2019-12-01
Trial ID
NCT04261465
Treatments Being Tested